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This work reports optical markers for the facilitated diffu
sion of nucleosides. Nucleoside transporters recognize the
sugar moiety; the nucleobase is secondary. We describe
iridium(III) based emitters bound covalently to deoxyribose
sugars through b glycoside linkages. These non natural nu
cleosides assemble in copper catalyzed [3+2] cycloaddition
reactions of azides with terminal alkyne precursors. Metala
tion follows in thermal reactions with iridium(III) dimers.[53]
Instead of a nucleobase, the deoxyribose sugar supports cy
clometalated iridium(III) at the 1’ position. The new probes
are visible light emitters. Their syntheses and optical proper
ties are disclosed, along with crystallographic findings, cellu
lar experiments, and density functional theory calculations
of a representative complex.
Results and Discussion
Synthesis : Synthesis of a chelating deoxyribose ligand pro
ceeded as in Scheme 1. Concentrated hydrochloric acid
(1.5 equiv) was treated with 2 deoxy d ribose in methanol.
The methyl protected product 2 was treated with para toluo
yl chloride in pyridine to protect the 3’ and 5’ hydroxyls.
Compound 3 was converted to chloro Hoffer sugar 4 with
an HCl solution in glacial acetic acid generated by adding
acetyl chloride to an aqueous solution of acetic acid. The
chloro sugar dissolved in N,N dimethylformamide was treat
ed with sodium azide to yield the two anomers, a and b, of
protected azido sugar 5. The resulting diastereomeric mix
ture was separated by silica gel column chromatography.
Deprotection with sodium methoxide in dry methanol af
forded azidodeoxyribose 6. Copper catalyzed [3+2] cyclo
addition with 2 ethynylpyridine produced 7 after purifica
tion by silica gel column chromatography. Ligand 7 recurs in
all complexes in this work.[54 56]
Metallonucleosides were prepared by the treatment of 7
with known, chloro bridged iridium(III) dimers. An example
appears in Scheme 2. Ambient workup and precipitation
yielded the products as analytically pure solids in isolated
yields ranging from 62 79%. Scheme 3 enumerates the non
nucleoside ligands.
Vapor diffusion of pentane into a chloroform solution af
forded diffraction quality single crystals of [Ir(ppy)2(7)]
(PF6). A thermal ellipsoid depiction appears in Figure 1. Iri
dium carbon bond lengths are 2.017(4) and 2.019(7) ; the
nucleoside pyridyl and triazolyl nitrogen donors exert simi
lar trans influences. Iridium pyridyl nitrogen bond lengths
are 2.047(5) and 2.048(6)  for the 2 phenylpyridine ligands,
and 2.163(5)  for the nucleoside. The Ir Ntriazolyl distance is
2.141(4) , also reflecting a trans disposition to carbon.
Counterion and intraligand metrics, including those of the
sugar, are unexceptional.
New complexes were characterized by absorption and lu
minescence spectroscopies. Absorption features appear in
the visible region from about 250 435 nm, with more intense
bands in the ultraviolet. The weaker, longer wavelength fea
tures have been ascribed to spin allowed and spin forbidden
metal to ligand charge transfer (MLCT) transitions,[57] and
the more intense bands of shorter wavelength to ligand
p* !p transitions. Such absorption features are common
place among C^N chelated complexes of iridium(III).[58]
Luminescence : The new complexes emit in fluid solution
and in low temperature glasses. Normalized emission spec
tra at 77 K appear in Figure 2; emission maxima and life
times are gathered in Table 1. The cyclometalating ligands
modulate the luminescence; emission colors span the visible
Scheme 1. Synthesis of nucleoside 7.
Scheme 2. Synthesis of a typical iridium(III) metallonucleoside.
Scheme 3. Cyclometalating ligands.
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spectrum. Vibronic structure is pronounced. Their microsec
ond scale emission lifetimes indicate phosphorescence.
Taken together, the spectra indicate emitting states of con
siderable ligand character, with origins that range from
3MLCT to ligand centered.
Calculations : The complex [Ir(btp)2(7)]
+ was selected for
density functional theory calculations because of its long
wavelength emission, which minimizes interference from
cellular autofluorescence. A frontier Kohn Sham orbital
energy level diagram is shown in Figure 3a with selected or
bital depictions in Figure 3b. The highest occupied Kohn
Sham orbital (HOMO) is delocalized over iridium (20%)
and the cyclometalating btp ligands (79%); percentages are
of electron density as calculated by a Mulliken population
analysis.[59] The lowest unoccupied Kohn Sham orbital
(LUMO) concentrates (91%) on the pyridyl triazolyl arm.
Because the LUMO resides on the ancillary (pyridyl tria
zolyl) ligand, the red shifted absorption profile is attributa
ble to high energy, occupied btp p orbitals.
Cellular uptake of 8 : Transport of compound 8 into KB3
1 cells was evaluated using fluorescence microscopy analysis.
Figure 1. Thermal ellipsoid representation (50% probability) of the
cation of [Ir(ppy)2(7)](PF6) (8) along c. Hydrogen atoms and counterion
are omitted for clarity. A partial atom labeling scheme is indicated. Se
lected interatomic distances []: Ir1 C34, 2.017(4); Ir1 C23, 2.019(7);
Ir1 N6, 2.047(5); Ir1 N5, 2.048(6); Ir1 N1, 2.141(4); Ir1 N4, 2.163(5).
Selected angles [8]: N1 Ir1 N4, 76.7(3); C23 Ir1 N5, 80.2(3).
Figure 2. Normalized emission spectra (77 K) of new complexes in
2 methyltetrahydrofuran glass.
Table 1. Emission wavelengths (lem), lifetimes (t), and quantum yields
(fem) of iridium(III) complexes as PF6 salts at 295 and 77 K in 2 methyl
tetrahydrofuran.
Sample 295 K 77 K
lem [nm] t [ms] fem
[a] lem [nm] t [ms]
[Ir(ppy)2(7)]
+ 475 1.5 0.15 475 4.4
[Ir(tpy)2(7)]
+ 475 1.6 0.13 475 5.8
[Ir(bzq)2(7)]
+ 520 6.8 0.026 500 62
[Ir(btp)2(7)]
+ 592 7.2 0.044 582 13
[Ir(pq)2(7)]
+ 565 1.2 0.064 542 4.6
[a]10%; absorbance of solutions was 0.1.
Figure 3. a) Frontier Kohn Sham orbital energy level diagram of
[Ir(btp)2(7)]
+ . Continuum water solvation is included. b) Plots of selected
orbitals (isodensity level is 0.03 a.u.). A color depiction of this Figure ap
pears as the Supporting Information.
15926
In these experiments, human epidermal carcinoma cells,
KB3 1, were treated with a fixed concentration (50 mm) of 8,
and images of treated cells were taken at variable time
points using an excitation wavelength of 315 nm and an
emission wavelength of 510 nm. To provide higher quality
images, cells were also stained with Hoechst 33342 to stain
their nuclei, which appeared blue (excitation wavelength of
340 nm and an emission wavelength of 480 nm). Images pro
vided in Figure 4a show an increase in green fluorescence
signal that, in some cases, appears to co localize with the
nuclei. In addition, the increase in green fluorescence signal
that reflects intracellular accumulation of 8 in KB3 1 cells
occurs in a time dependent manner, reaching a maximal
amount in 24 h.
The dose dependency of the uptake of 8 was similarly
evaluated. In these experiments, KB3 1 cells were treated
with variable concentrations of
compound 8 for a fixed time in
terval (24 h). Representative
data in Figure 4b show that
KB3 1 cells treated with 50 mm
8 show more intense phosphor
escence than cells treated with
10 mm 8. As before, the higher
emission intensity reflects intra
cellular accumulation of 8 that
occurs in a dose dependent
manner.
We next evaluated if the
uptake of 8 occurs by passive
diffusion or by the activity of
one or more nucleoside trans
porters. This was accomplished
by quantifying the ability of the
natural nucleoside, 2’ deoxyade
nosine, to block the uptake of
the fluorescent analogue. This nucleoside acts as a substrate
for all nucleoside transporters, including hENT and hCNT
family members,[60 65] and should thus function as a broad
spectrum inhibitor for the uptake of 8. Cells were treated
with DMSO (vehicle) or 2’ deoxyadenosine (10 or 200 mm)
for 24 h prior to treatment with 10 or 50 mm of compound 8.
Data provided in Figure 5 show that the inclusion of 10 mm
2’ deoxyadenosine exerts little effect on the uptake of either
low (10 mm) or high (50 mm) concentrations of 8. In contrast,
pretreatment with 200 mm 2’ deoxyadenosine attenuates the
phosphorescence signal caused by the uptake of 8. The abili
ty of high concentrations of 2’ deoxyadenosine to block
uptake suggests that the transport of 8 is catalyzed by one
or more hENT family members. This suggestion is based on
the fact that hENT family members have weaker affinity for
natural nucleosides, such as 2 deoxyadenosine, compared to
hCNTs.[66,67]
The accumulation of 8 in
KB3 1 cells was also quantified
using a plate reader assay.
KB3 1 cells were seeded onto
12 well plates at a density of
200000 cells per well. After
overnight incubation to allow
cell attachment, the cells were
treated with variable concentra
tions of 8 for an additional
48 h. After 48 h, the medium
containing 8 was removed, and
the cells were washed twice
with 200 mL of phosphate buf
fered saline (PBS). Each wash
ing step was performed for
10 min at 37 8C. All washes
were collected and analyzed as
described in the Experimental
Figure 4. a) Time dependent accumulation of 8 into human epidermal carcinoma cell lines, KB3 1. Images of
cells treated with 50 mm of 8 were taken 4, 8, 12, and 24 h post treatment. b) Dose dependent accumulation of
8 into KB3 1 cells. Cells were incubated with 10 and 50 mm of 8 for 24 h. Compound 8 shows green fluores
cence whereas the nuclei are stained with Hoechst 33342 (blue). Scale bars (100 mm) are provided for refer
ence.
Figure 5. The uptake of 8 is dependent on nucleoside transporter activity. KB3 1 cells were treated with varia
ble concentration of 8 (10 and 50 mm) in the absence and presence of increasing concentrations of 2’ deoxyade
nosine. Cell images were taken after 24 h of exposure to 8. Compound 8 shows green fluorescence whereas
nuclei are stained with Hoechst 33342 (blue). Scale bars (100 mm) are provided for reference.
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Section to measure the concentration of unbound 8. The
cells were then treated with 0.25% trypsin and harvested by
centrifugation. The supernatant was removed, and the cells
were again washed with 1 mL of PBS at 37 8C to remove un
bound and bound nucleoside. After this last wash step, the
cells were lysed using 0.1% Triton X 100 in 1PBS. The
amount of 8 present in the lysate was then measured using
a fluorescent plate reader (lex=340 nm/lem=480 nm). The
data provided in Figure 6 show a dependency on the fluores
cence signal as a function of the concentration of 8, thus val
idating that 8 accumulates inside KB3 1 cells.
Conclusion
Described herein is a synthetic strategy with which deoxyri
bose sugars are linked to chelating pyridyl triazoles. An effi
cient method has been developed that attaches these sugar
bearing ligands to cyclometalated iridium(III). The resulting
assemblies are luminescent. Choice of the cyclometalating
C^N ligand controls emission colors, and lumophores of
many hues can be prepared.
Membrane bound enzymes translocate nucleosides from
extracellular space into the cytosol in the first step of nu
cleoside metabolism. Most nucleoside transport enzymes
support sweeping variations in the nucleobase. The pendant
(deoxy)sugar is the recognition site of nucleoside substrates.
Chemical tags that monitor nucleoside transport are few,
and studies of transport in vivo are hindered. The conjugates
herein join an emissive complex to a deoxyribose sugar.
They are potential photoactive surrogates of natural nucleo
sides; their biodisposition can be tracked optically. These
studies are in progress.
Experimental Section
Materials and methods : Experimental procedures involving air or mois
ture sensitive substances were performed under argon using either
Schlenk line techniques or in a nitrogen filled MBraun drybox. Anhy
drous solvents were used directly from an MBraun solvent purification
system or were purchased from Sigma Aldrich. 1H NMR experiments
were performed on a Varian 400 FT NMR spectrometer operating at
399.7MHz. 1H chemical shifts are reported in parts per million (d), mea
sured from tetramethylsilane (0 ppm) and are referenced to residual sol
vent in CDCl3 (7.26 ppm), [D6]acetone (2.05 ppm) or CD2Cl2 (5.32 ppm)
for 1H NMR. 13C{1H} NMR spectra were recorded on a Varian INOVA
AS 600 spectrometer operating at 150.0 Hz. 13C NMR chemical shifts are
reported in parts per million (d), measured from tetramethylsilane
(0 ppm) and are referenced to solvent residuals in CDCl3 (77.00 ppm) or
CD2Cl2 (54.00 ppm). The configuration of the nucleoside was confirmed
by 1H NMR NOE difference spectroscopy on a Varian INOVA AS 600
instrument. High resolution electrospray ionization mass spectrometry
(Hi Res ESI MS) experiments were performed on an IonSpec HiRes
ESI FTICRMS at the University of Cincinnati Mass Spectrometry facili
ty. Solvents were degassed by bubbling argon for 20 min prior to use for
UV/Vis and luminescence measurements. UV/Vis and luminescence data
were recorded using a Cary 5G UV/Vis/NIR spectrometer and a Cary
Eclipse spectrometer, respectively. Thin layer chromatography (TLC)
was carried out using Whatman silica gel UV254 plates. Column chroma
tography was performed using Fisher Scientific silica gel, sizes 32 63. El
emental analyses were carried out by Robertson Microlit Laboratories,
Ledgewood, NJ.
Chemicals from commercial sources were used as received. 2 Deoxy d
ribose, pyridine, p toluoyl chloride, acetyl chloride, 2 ethoxyethanol, and
sodium methoxide (NaOMe) were purchased from Acros Organics.
Sodium azide (NaN3), N,N diisopropylethylamine (DIPEA) and cop
per(I) iodide (CuI) were purchased from Sigma Aldrich. Iridium(III)
chloride (IrCl3·3H2O) and ammonium hexafluorophosphate (NH4PF6)
were purchased from Strem Chemicals.
Hoffers a chlorosugar (1 a chloro 3,5 di (O p toluoyl) 2 deoxy d
ribose) was synthesized with a slight modification of the first step of an
established procedure[68] in which an equivalent amount of concentrated
hydrochloric acid was used in place of dissolving hydrogen chloride gas
in methanol. Cyclometalated IrIII m chloro bridged dimers, (C^N)2Ir(m
Cl)2Ir(C^N)2 (abbreviated as [{Ir(C^N)2(m Cl)}2]), were synthesized with
the method reported by Nonoyama;[69] IrCl3·3H2O was refluxed with 2
2.5 equiv cyclometalating ligand in a 3:1 mixture of 2 ethoxyethanol and
water. Synthesis and characterization of [{Ir(ppy)2(m Cl)}2],
[70] [{Ir(tpy)2
(m Cl)}2],
[71] [{Ir(bzq)2(m Cl)}2],
[72] [{Ir(pq)2(m Cl)}2],
[73] and [{Ir(btp)2(m
Cl)}2]
[74] were reported previously.
1-b-Azido-3,5-di-(O-p-toluoyl)-2-deoxy-d-ribose (5b): NaN3 (0.390 g,
5.99 mmol) was added to a mixture of a chlorosugar 4 (1.50 g,
3.85 mmol) in dry DMF (50 mL), stirred at RT for 30 min. The mixture
was vigorously stirred at RT for 2 h in an inert atmosphere as the reac
tion was tracked by TLC. After completion of the reaction, EtOAc
(100 mL) was added to the mixture to form a uniform organic layer. The
organic layer was washed with water (2100 mL) followed by brine
(150 mL) and dried (over anhydrous Na2SO4). Evaporation under re
duced pressure afforded the crude product mixture (1.4 g, 92%, b/a
1:1), which was resolved by chromatography using diethyl ether/hex
anes (1:9 v/v) mixture. Compound 5b was eluted as the first fraction.
Yield: 0.823 g (54%); Rf=b : 0.55 (diethyl ether/hexanes=30:70);
1H NMR (400MHz, CDCl3): d=7.97 (d, 2H, J=8.1 Hz), 7.89 (d, 2H, J=
8.2 Hz), 7.24 7.21 (m, 4H), 5.70 (t, 1H, J=5.2 Hz), 5.56 (td, 1H, J=5.5,
2.4 Hz), 4.59 4.50 (m, 3H), 2.42 2.39 ppm (m, 8H); HRMS: calcd for
C21H21N3NaO5 [M+Na]
+ : 418.1379; found: 418.1376.
1-a-Azido-3,5-di-(O-p-toluoyl)-2-deoxy-d-ribose (5a): Collected as the
second fraction from the column. Yield: 0.7 g (46%); Rf=a : 0.48 (diethyl
ether/hexanes=30:70); 1H NMR (400MHz, CDCl3): d=7.96 (d, 2H, J=
8.3 Hz), 7.91 (d, 2H, J=8.2 Hz), 7.27 7.23 (m, 4H), 5.71 (d, 1H, J=
5.6 Hz), 5.51 5.48 (m, 1H), 4.72 (q, 1H, J=3.8 Hz), 4.63 4.50 (m, 2H),
Figure 6. Quantifying the cellular accumulation of compound 8 in KB3
1 cells. Cells were treated with variable concentrations of 8 for 48 h and
the fluorescence intensities of lysed cells were measured with a fluores
cence plate reader. Data points for lysed KB3 1 cells are provided as cir
cles and data points for the collected supernatants are provided as
squares. These experiments represent an average of three or four inde
pendent experiments performed on different days. The error bars repre
sent standard deviations.
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2.58 2.52 (m, 1H), 2.42 (s, 3H), 2.41 (s, 3H), 2.25 2.21 ppm (m, 1H);
HRMS: calcd for C21H21N3NaO5 [M+Na]
+ : 418.1379; found: 418.1366.
1-b-Azido-2-deoxy-d-ribose (6): Dry MeOH (50 mL) followed by sodium
methoxide (0.410 g, 7.58 mmol) were added to a dry round bottom flask
loaded with 5b (0.950 g, 2.4 mmol). The reaction mixture was stirred
under inert atmosphere at RT for 24 h and monitored by TLC. After this
time, the solvent was removed under vacuum. The residue was loaded on
a silica gel column, and the desired product 6 was isolated when eluted
with 5% MeOH in diethyl ether. Yield: 0.310 g (81%); Rf=0.60 (metha
nol/diethyl ether=5:95); 1H NMR (400MHz, CDCl3): d=5.55 (t, 1H,
J=4.0 Hz), 4.39 (d, 1H, J=4.8 Hz), 3.95 3.92 (m, 1H), 3.75 3.66 (m,
2H), 2.15 2.11 ppm (m, 2H); HRMS: calcd for C5H9N3NaO3 [M+Na]
+ :
182.0542; found: 182.0545.
1-(1’-b-2’-Deoxy-d-ribofuranosyl)-4-(5-(2-pyridinyl))-1,2,3-triazole (7):
Compound 6 (0.540 g, 3.39 mmol) was dissolved in a mixture of THF
(10 mL) and toluene (40 mL). 2 Ethynylpyridine (0.54 mL, 5.35 mmol),
DIPEA (2.7 mL, 15.5 mmol), and CuI (0.646 g, 3.39 mmol) were added
to the reaction mixture. The solution was heated to reflux. The reaction
was complete after 24 h, as monitored by TLC. The solvent was removed
by rotary evaporation. The crude reaction mixture was loaded on a silica
gel column packed with 1:1 v/v diethyl ether/hexanes. The desired prod
uct 7 was isolated when the eluant polarity was increased to 1:9 v/v
MeOH/diethyl ether. Yield: 0.665 g (75%); Rf=0.20 (methanol/diethyl
ether=5:95); 1H NMR (400MHz, CDCl3): d=8.49 (d, 1H, J=4.0 Hz),
8.46 (s, 1H), 8.09 (d, 1H, J=8.3 Hz), 7.77 (td, 1H. J=6.0, 1.6 Hz), 7.24
7.21 (m, 1H), 6.42 (tapp, characteristic peak for b anomer, 1H, J=6.7 Hz),
4.77 (d, 1H, J=4.8 Hz), 4.13 (d, 1H, J=3.9 Hz), 3.88 3.72 (m, 2H), 2.89
2.83 (m, 1H), 2.63 2.57 ppm (m, 1H); 13C NMR (150MHz, CDCl3): d=
149.72, 149.23, 148.03, 137.24, 123.14, 121.53, 120.43, 88.96, 88.39, 71.69,
62.61, 41.67 ppm; HRMS: calcd for C12H14N4NaO3 [M+Na]
+ : 285.0964;
found: 285.0974; elemental analysis calcd for C12H14N4O3: C 54.96, H
5.38, N 21.36; found: C 55.12, H 5.42, N 21.34.
[Ir(ppy)2(7)]PF6 (8): [{Ir(ppy)2(m Cl)}2] (0.040 g, 0.037 mmol) was sus
pended in acetonitrile (20 mL). To this was added a 10 mL THF solution
of compound 7 (0.024 g, 0.092 mmol) followed by NH4PF6 (0.012 g,
0.076 mmol). After being purged with argon, the reaction mixture was
heated to 45 8C and left to stir for 12 h. The reaction was complete after
this time period as indicated by TLC. The solvent was removed under re
duced pressure to render a dark orange residue. The crude reaction mix
ture was washed with THF, water, and ice cold acetone followed by di
ethyl ether and pentane. The product was vacuum dried to give analyti
cally pure compound. Yield: 0.053 g (75%); 1H NMR (400MHz,
CD2Cl2): d=9.23 (d, 1H, J=3.2 Hz), 8.25 (dd, 1H, J=5.0, 4.2 Hz), 8.01
(t, 1H, J=7.8 Hz), 7.95 7.92 (m, 2H), 7.83 (d, 1H, J=5.4 Hz), 7.81 7.76
(m, 2H), 7.72 7.68 (m, 3H), 7.50 (dd, 1H, J=6.3, 5.3 Hz), 7.29 (t, 1H,
J=7.3 Hz), 7.10 6.96 (m, 4H), 6.92 (t, 1H, J=7.1 Hz), 6.86 (t, 1H, J=
7.6 Hz), 6.50 6.41 (m, 1H), 6.31 6.28 (m, 2H), 4.73 4.62 (m, 1H), 4.12
4.08 (m, 1H), 3.96 3.80 (m, 2H), 2.76 2.53 ppm (m, 2H); 13C NMR
(150MHz, CD2Cl2): d=168.59, 167.95, 150.83, 150.04, 149.94, 149.82,
149.22, 149.07, 146.68, 144.56, 140.18, 138.71, 138.64, 132.50, 132.07,
131.12, 130.43, 127.13, 125.32, 124.92, 124.46, 124.36, 124.13, 124.00,
123.79, 123.69, 123.31, 122.86, 120.19, 91.88, 89.11, 70.97, 62.04,
42.82 ppm; UV/Vis (acetonitrile): lmax (e)=249 (27000), 380 nm
(4000 m 1 cm 1); emission (acetonitrile): lex (Int.)=478 (190), 506 nm
(178); HRMS: calcd for C34H30IrN6O3 [M PF6]
+ : 763.2003; found:
763.2004; elemental analysis calcd for C34H30F6IrN6O3P: C 44.98, H 3.33,
N 9.26; found: C 45.21, H 3.52, N 9.35.
[Ir(tpy)2(7)]PF6 : [{Ir(tpy)2(m Cl)}2] (0.046 g, 0.041 mmol) was suspended
in dry acetonitrile (25 mL). To this was added a solution of compound 7
(0.026 g, 0.099 mmol) dissolved in 10 mL dry THF, followed by NH4PF6
(0.014 g, 0.086 mmol). After being purged with argon, the reaction mix
ture was sealed and heated to 45 8C. The reaction was complete after
12 h as indicated by TLC. The solvent was removed under reduced pres
sure to render a dark orange residue. The crude reaction mixture was
washed with THF, water and ice cold acetone, followed by diethyl ether
and pentane. The remaining product was dried under vacuum to give an
alytically pure compound. Yield: 0.047 g (62%); 1H NMR (400MHz,
[D6]acetone): d=9.43 (d, 1H, J=5.9 Hz), 8.40 (dd, 1H, J=5.3, 3.2 Hz),
8.19 (t, 1H, J=7.8 Hz), 8.14 (d, 2H, J=8.3 Hz), 7.95 7.85 (m, 4H), 7.78
7.69 (m, 3H), 7.55 (t, 1H, J=5.6 Hz), 7.13 7.05 (m, 2H), 6.86 (d, 1H, J=
7.4 Hz), 6.78 (d, 1H, J=7.5 Hz), 6.46 (q, 1H, J=8.8 Hz), 6.17 6.14 (m,
2H), 4.63 4.48 (m, 1H), 4.07 4.08 (m, 1H), 3.76 3.62 (m, 2H), 2.64 2.53
(m, 2H), 2.08 (s, 3H), 2.05 ppm (s, 3H); 13C NMR (150MHz, CD2Cl2):
d=168.56, 167.97, 150.83, 150.03, 149.92, 149.85, 149.19, 148.89, 146.81,
141.91, 141.84, 141.48, 140.69, 140.03, 138.51, 138.45, 133.19, 132.75,
127.03, 125.21, 124.82, 124.36, 124.29, 123.85, 123.67, 123.52, 123.39,
123.10, 119.79, 91.76, 89.10, 70.78, 61.92, 42.78, 22.05 ppm (2 CH3 C);
UV/Vis (acetonitrile): lmax (e)=249 (15000), 267 (sh, 14000), 378 nm
(3000 m 1 cm 1); emission (acetonitrile): lex (Int.)=480 (160), 508 nm
(147); HRMS: calcd for C36H34IrN6O3 [M PF6]
+ : 791.2316; found:
791.2320; elemental analysis calcd for C36H34F6IrN6O3P: C 46.20, H 3.66,
N 8.98; found: C 46.51, H 3.85, N 9.21.
[Ir(bzq)2(7)]PF6 : [{Ir(bzq)2(m Cl)}2] (0.045 g, 0.038 mmol) was suspended
in dry acetonitrile (20 mL). To this was added a 10 mL THF solution of
compound 7 (0.025 g, 0.096 mmol) followed by NH4PF6 (0.016 g,
0.096 mmol). The reaction mixture was purged with argon, heated to
45 8C, and left to stir for 12 h. The reaction was complete after this time
period as indicated by TLC. The solvent was removed under reduced
pressure to render a dark orange residue. The crude reaction mixture
was washed with THF, water, and ice chilled methanol, followed by di
ethyl ether and pentane. The product was vacuum dried to give analyti
cally pure compound. Yield: 0.058 g (79%); 1H NMR (400MHz,
CD2Cl2): d=9.48 (d, 1H, J=13.7 Hz), 8.31 8.29 (m, 3H), 8.06 (ddd, 1H,
J=8.9, 5.3, 1.2 Hz), 7.91 7.85 (m, 4H), 7.78 (t, 1H, J=6.5 Hz), 7.72 7.68
(m, 2H), 7.51 (d, 1H, J=7.6 Hz), 7.47 7.37 (m, 3H), 7.18 7.12 (m, 2H),
7.10 (td, 1H, J=7.2, 1.4 Hz), 6.40 6.24 (m, 3H), 4.79 4.62 (m, 1H), 3.98
3.94 (m, 1H), 3.85 3.82 (m, 2H), 2.70 2.36 ppm (m, 2H). 13C NMR
(150MHz, CD2Cl2): d=158.10, 157.52, 151.21, 150.41, 149.44, 149.06,
148.37, 148.13, 146.42, 143.19, 141.57, 141.32, 140.15, 137.70, 134.86,
134.56, 130.50, 130.39, 130.29, 129.83, 129.74, 129.41, 127.79, 126.92,
124.88, 124.44, 124.10, 123.85, 122.95, 122.74, 122.37, 121.30, 120.80, 91.60,
88.92, 69.79, 61.11, 42.43 ppm; UV/Vis (acetonitrile): lmax (e)=242
(14000), 315 nm (8000 m 1 cm 1); emission (acetonitrile): lex (Int.)=516
(176), 540 nm (sh, 150); HRMS: calcd for C38H30IrN6O3 [M PF6]
+ :
811.2003; found: 811.2004; elemental analysis calcd for C38H30F6IrN6O3P:
C 47.75, H 3.16, N 8.79; found: C 47.86, H 3.36, N 9.11.
[Ir(btp)2(7)]PF6 : [{Ir(btp)2(m Cl)}2] (0.050 g, 0.038 mmol) was suspended
in dry acetonitrile (25 mL). To this was added a solution of compound 7
(0.026 g, 0.098 mmol) in 10 mL dry THF, followed by NH4PF6 (0.014 g,
0.086 mmol). After being purged with argon, the reaction mixture was
sealed and heated to 45 8C. The reaction was complete after 12 h as indi
cated by TLC. The solvent was removed under reduced pressure to
render a brick red residue. The crude reaction mixture was washed with
THF, water and ice cold methanol, followed by diethyl ether and pen
tane. The remaining product was dried under vacuum to give analytically
pure compound. Yield: 0.061 g (78%); 1H NMR (400MHz,
[D6]acetone): d=9.48 (d, 1H, J=9.0 Hz), 8.47 (d, 1H, J=5.6 Hz), 8.27
(d, 1H, J=6.3 Hz), 8.07 7.98 (m, 2H), 7.94 7.80 (m, 3H), 7.65 7.30 (m,
5H), 7.20 (dd, 2H, J=8.9, 6.3 Hz), 7.10 (t, 2H, J=6.4 Hz), 6.89 (dd, 2H,
J=7.6, 6.1 Hz), 6.45 6.40 (m, 1H), 6.19 6.09 (m, 2H), 4.70 4.39 (m, 1H),
4.21 3.92 (m, 1H), 3.76 3.52 (m, 2H), 2.74 2.52 ppm (m, 2H); UV/Vis
(acetonitrile): lmax (e)=283 (31000), 325 (20000), 435 nm (7500 m
1 cm 1);
emission (acetonitrile): lex (Int.)=593 (180), 637 nm (126); HRMS: calcd
for C38H30IrN6O3S2 [M PF6]
+ : 875.1445; found: 875.1437; elemental anal
ysis calcd for C38H30F6IrN6O3PS2: C 44.75, H 2.96, N 8.24; found: C 44.88,
H 3.19, N 8.27.
[Ir(pq)2(7)]PF6 : [{Ir(pq)2(m Cl)}2] (0.040 g, 0.031 mmol) was suspended in
dry acetonitrile (20 mL). To this was added a solution of 7 in 10 mL dry
THF, followed by NH4PF6 (0.013 g, 0.078 mmol). After being purged with
argon, the reaction mixture was heated to 45 8C and left to stir for 16 h.
The reaction was complete after this time period as indicated by TLC.
The solvent was removed under reduced pressure to render a dark
orange residue. The crude reaction mixture was washed with THF, water
and ice cold acetone followed by diethyl ether and pentane. The product
was vacuum dried to give analytically pure compound. Yield: 0.048 g
(76%); 1H NMR (400MHz, CD2Cl2): d=8.90 (m, 1H), 8.28 8.13 (m,
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4H), 8.08 8.05 (m, 2H), 7.95 (q, 1H, J=5.8 Hz), 7.77 7.69 (m, 4H), 7.60
(q, 1H, J=9.1 Hz), 7.39 7.11 (m, 7H), 6.93 (q, 1H, J=8.2 Hz), 6.86 (q,
1H, J=7.4 Hz), 6.79 6.75 (m, 1H), 6.69 (d, 1H, J=7.6 Hz), 6.52 (dd, 1H,
J=8.5, 6.7 Hz), 6.30 6.26 (m, 1H), 4.60 4.27 (m, 1H), 3.96 3.95 (m, 1H),
3.71 3.63 (m, 2H), 2.57 2.22 ppm (m, 2H); 13C NMR (150MHz,
CD2Cl2); d=171.10, 170.21, 151.59, 149.67, 148.51, 148.31, 148.08, 147.21,
146.88, 146.41, 140.43, 140.19, 139.85, 135.77, 134.94, 131.99, 131.76,
131.09, 130.59, 129.67, 129.32, 128.30, 128.03, 127.51, 127.37, 127.08,
126.97, 126.64, 126.03, 125.79, 125.25, 123.68, 123.57, 123.26, 123.05,
117.88, 117.80, 91.31, 89.11, 69.81, 61.48, 41.99 ppm; UV/Vis (acetoni
trile): lmax (e)=234 (8200), 264 (7600), 332 nm (4000 m
1 cm 1); emission
(acetonitrile): lex (Int.)=567 nm (245); HRMS: calcd for C42H34IrN6O3
[M PF6]
+ : 863.2322; found: 863.2328; elemental analysis calcd for
C42H34F6IrN6O3P: C 50.05, H 3.40, N 8.34; found: C 50.15, H 3.77, N 8.60.
Luminescence measurements : Steady state luminescence spectra were re
corded at room temperature on a Cary Eclipse fluorescence spectropho
tometer or on an automated Photon Technology International (PTI)
QM 4 fluorimeter equipped with a 150 W Xe arc lamp and a Hamamatsu
R928 photomultiplier tube. Excitation light was excluded with suitable
glass filters. Sample solutions were added to a quartz ESR tube equipped
with a Teflon valve, freeze pump thaw degassed (four cycles, 1
10 5 Torr), and sealed. Low temperature emission spectra were recorded
in rigid solvent glass at 77 K by immersion of the sealed ESR tubes into
a liquid nitrogen filled dewar. Time resolved phosphorescence lifetime
data were recorded on a nanosecond laser system described previously.[75]
Emission quantum yields (232 8C) were measured[76] in deoxygenated
2 methyltetrahydrofuran by referencing sample luminescence intensities
to those of optically dilute standards of 9,10 diphenylanthracene (fem=
0.9) in cyclohexane.[77] Quantum yields, f, were computed by using Equa
tion (1):
s ¼ r

Arh
2
sDs
Ash
2
rDr

ð1Þ
where r and s indicate reference and sample, respectively, A is the ab
sorbance at wavelength lexc, h is the refractive index of the solvent, and
D is the integrated area beneath the absorption spectrum.
Cell culture procedures : KB3 1 cells were cultured at 37 8C in humidified
air with 5% CO2 and maintained in Dulbeccos modified Eagles
medium (Mediatech, VA) supplemented with 10% fetal bovine serum
(USA Scientific), 100 UmL 1 penicillin (Invitrogen, NY), 100 mgmL 1
streptomycin and 250 mL gentamicin. The doubling time for these cells is
approximately 24 h. In cell based experiments, a fixed amount of com
pound 8 was dissolved in 100% DMSO to obtain a final stock concentra
tion of 100 mm. Serial dilutions of compound 8 (10 0.01 mm) were then
made from this stock solution using 100% DMSO as the co solvent.
Visualizing the cellular uptake of compound 8 by microscopy : The cellu
lar uptake of compound 8 was visualized by microscope imaging of KB3
1 cells. Cells were plated on 35 mm glass bottom microwell dishes and
pre incubated in the absence or presence of variable concentrations of 2’
deoxyadenosine. After 24 h, cells were treated with variable concentra
tions of compound 8 (0 200 mm) for time periods varying from 4 to 48 h.
Cells were then washed twice with 1PBS, fixed with 4% paraformalde
hyde, and washed twice with 1PBS. Images were obtained using
a Nikon (TE 2000 S) microscope with UV lamp. Positive controls were
obtained measuring cellular uptake of Hoechst 33342 at a final concen
tration of 5 mgmL 1. For the detection of compound 8, an excitation
wavelength (lex) of 365 nm and an emission wavelength (lem) of 477 nm
were used.
Studies for the quantification of compound 8 were performed by seeding
cells onto 12 well plates at a density of 200000 cells per well. After 24 h,
cells were treated with variable concentrations of compound 8 (0
200 mm) for 24 48 h. Cells were treated with 0.25% trypsin and harvested
by centrifugation. The supernatant was removed and then washed with
PBS. Cells were lysed with 0.1% Triton X 100 in 1PBS and then ob
served using a fluorescent plate reader (lex=340 nm/lem=480 nm).
X-ray single crystal structure analysis : Single crystal X ray data were col
lected on a Bruker AXS SMARTAPEX CCD diffractometer using mon
ochromatic MoKa radiation with the omega scan technique. The unit cells
were determined using SMART[78] and SAINT+ .[79] Data collection for
all crystals was conducted at 100 K ( 173 8C). All structures were solved
by direct methods and refined by full matrix least squares against F2 with
all reflections using SHELXTL.[80] Refinement of extinction coefficients
was found to be insignificant. All non hydrogen atoms were refined ani
sotropically. Hydrogen atoms were placed in standard calculated posi
tions and were refined with an isotropic displacement parameter 1.2
times that of the adjacent carbon or oxygen.
Computations : Spin restricted density functional theory calculations
were executed with Gaussian09 (rev.A.02).[81] Geometries were fully op
timized. Calculations employed the exchange and correlation functionals
of Perdew, Burke, and Ernzerhof,[82] and the TZVP basis set. For iridium,
the Stuttgart Dresden (SDD) effective core potential and basis set were
used; scalar relativistic effects are included implicitly. Harmonic frequen
cy calculations returned all real vibrational frequencies. The calculations,
including geometry optimizations, impose continuum solvation in water,
using the integral equation formalism of Tomasis polarizable continuum
model.[83 86] Population analyses were performed with the AOMix CDA
software of Gorelsky.[87, 88]
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